Recursion (Nasdaq: RXRX) will report its Q3 2025 financial results on November 5, 2025, before the financial markets open. An earnings call will follow at 8:00 am ET / 6:00 am MT / 1:00 pm GMT, streamed on X, LinkedIn, and YouTube. Investors can submit questions for the call online. Recursion is a clinical stage TechBio company using technology to advance medicine. The company has a platform generating a vast dataset in biology and chemistry to improve lives. Recursion is headquartered in Salt Lake City and is part of BioHive, a Utah life sciences collective. Learn more at www.recursion.com. The document contains forward-looking statements about business plans, performance, and risks, subject to uncertainties that may impact actual results.

Read more at GlobeNewswire: Recursion to Report Third Quarter 2025 Business Updates and